North America Mesenchymal Stem Cells Market by Manufacturers, Countries, Type and Application, Forecast to 2022


Report ID : RNR-90272 Category : Biotechnology Published Date : 22-May-17
Publisher : GlobalInfo Research Pages : 115 Format : PDF
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal.


Scope of the Report:
This report focuses on the Mesenchymal Stem Cells in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
    Lonza
    Thermo Fisher
    Bio-Techne
    ATCC
    MilliporeSigma
    PromoCell GmbH
    Genlantis
    Celprogen
    Cell Applications
    Cyagen Biosciences
    Axol Bioscience

Market Segment by Countries, covering
    United States
    Canada
    Mexico

Market Segment by Type, covers
    Human MSC
    Mouse MSC
    Rat MSC
    Other

Market Segment by Applications, can be divided into
    Research Institute
    Hospital
    Others

There are 15 Chapters to deeply display the North America Mesenchymal Stem Cells market.

Chapter 1, to describe Mesenchymal Stem Cells Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Mesenchymal Stem Cells, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Mesenchymal Stem Cells, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Mesenchymal Stem Cells market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Mesenchymal Stem Cells Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents
1 Market Overview
    1.1 Mesenchymal Stem Cells Introduction
    1.2 Market Analysis by Type
        1.2.1 Human MSC
        1.2.2 Mouse MSC
        1.2.3 Rat MSC
        1.2.4 Other
    1.3 Market Analysis by Applications
        1.3.1 Research Institute
        1.3.2 Hospital
        1.3.3 Others
    1.4 Market Analysis by Countries
        1.4.1 United States Status and Prospect (2012-2022)
        1.4.2 Mexico Status and Prospect (2012-2022)
        1.4.3 Canada Status and Prospect (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Lonza
        2.1.1 Profile
        2.1.2 Mesenchymal Stem Cells Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 Lonza Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.1.4 Business Overview
        2.1.5 Lonza News
    2.2 Thermo Fisher
        2.2.1 Profile
        2.2.2 Mesenchymal Stem Cells Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Thermo Fisher Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.2.4 Business Overview
        2.2.5 Thermo Fisher News
    2.3 Bio-Techne
        2.3.1 Profile
        2.3.2 Mesenchymal Stem Cells Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Bio-Techne Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.3.4 Business Overview
        2.3.5 Bio-Techne News
    2.4 ATCC
        2.4.1 Profile
        2.4.2 Mesenchymal Stem Cells Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 ATCC Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.4.4 Business Overview
        2.4.5 ATCC News
    2.5 MilliporeSigma
        2.5.1 Profile
        2.5.2 Mesenchymal Stem Cells Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 MilliporeSigma Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.5.4 Business Overview
        2.5.5 MilliporeSigma News
    2.6 PromoCell GmbH
        2.6.1 Profile
        2.6.2 Mesenchymal Stem Cells Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 PromoCell GmbH Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.6.4 Business Overview
        2.6.5 PromoCell GmbH News
    2.7 Genlantis
        2.7.1 Profile
        2.7.2 Mesenchymal Stem Cells Type and Applications
            2.7.2.1 Type 1
            2.7.2.2 Type 2
        2.7.3 Genlantis Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.7.4 Business Overview
        2.7.5 Genlantis News
    2.8 Celprogen
        2.8.1 Profile
        2.8.2 Mesenchymal Stem Cells Type and Applications
            2.8.2.1 Type 1
            2.8.2.2 Type 2
        2.8.3 Celprogen Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.8.4 Business Overview
        2.8.5 Celprogen News
    2.9 Cell Applications
        2.9.1 Profile
        2.9.2 Mesenchymal Stem Cells Type and Applications
            2.9.2.1 Type 1
            2.9.2.2 Type 2
        2.9.3 Cell Applications Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.9.4 Business Overview
        2.9.5 Cell Applications News
    2.10 Cyagen Biosciences
        2.10.1 Profile
        2.10.2 Mesenchymal Stem Cells Type and Applications
            2.10.2.1 Type 1
            2.10.2.2 Type 2
        2.10.3 Cyagen Biosciences Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.10.4 Business Overview
        2.10.5 Cyagen Biosciences News
    2.11 Axol Bioscience
        2.11.1 Profile
        2.11.2 Mesenchymal Stem Cells Type and Applications
            2.11.2.1 Type 1
            2.11.2.2 Type 2
        2.11.3 Axol Bioscience Mesenchymal Stem Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.11.4 Business Overview
        2.11.5 Axol Bioscience News
3 North America Mesenchymal Stem Cells Market Competition, by Manufacturer
    3.1 North America Mesenchymal Stem Cells Sales and Market Share by Manufacturer (2016-2017)
    3.2 North America Mesenchymal Stem Cells Revenue and Market Share by Manufacturer (2016-2017)
    3.3 North America Mesenchymal Stem Cells Price by Manufacturers (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Mesenchymal Stem Cells Manufacturer Market Share
        3.4.2 Top 5 Mesenchymal Stem Cells Manufacturer Market Share
    3.5 Market Competition Trend
4 North America Mesenchymal Stem Cells Market Analysis by Countries
    4.1 North America Mesenchymal Stem Cells Sales Market Share by Countries
    4.2 North America Mesenchymal Stem Cells Sales by Countries (2012-2017)
    4.3 North America Mesenchymal Stem Cells Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Mesenchymal Stem Cells by Type
    5.1 North America Mesenchymal Stem Cells Sales, Revenue and Market Share by Type (2012-2017)
        5.1.1 North America Mesenchymal Stem Cells Sales and Market Share by Type (2012-2017)
        5.1.2 North America Mesenchymal Stem Cells Revenue and Market Share by Type (2012-2017)
    5.2 Human MSC Sales Growth and Price
        5.2.1 North America Human MSC Sales Growth (2012-2017)
        5.2.2 North America Human MSC Price (2012-2017)
    5.3 Mouse MSC Sales Growth and Price
        5.3.1 North America Mouse MSC Sales Growth (2012-2017)
        5.3.2 North America Mouse MSC Price (2012-2017)
    5.4 Rat MSC Sales Growth and Price
        5.4.1 North America Rat MSC Sales Growth (2012-2017)
        5.4.2 North America Rat MSC Price (2012-2017)
    5.5 Other Sales Growth and Price
        5.5.1 North America Other Sales Growth (2012-2017)
        5.5.2 North America Other Price (2012-2017)
6 North America Market Segmentation Mesenchymal Stem Cells by Application
    6.1 North America Mesenchymal Stem Cells Sales Market Share by Application (2012-2017)
    6.2 Research Institute Sales Growth (2012-2017)
    6.3 Hospital Sales Growth (2012-2017)
    6.4 Others Sales Growth (2012-2017)
7 United States Mesenchymal Stem Cells Sales, Revenue, by Type, Application and Manufacturers
    7.1 United States Mesenchymal Stem Cells Revenue, Sales and Growth Rate (2012-2017)
    7.2 United States Mesenchymal Stem Cells Sales and Market Share by Type
    7.3 United States Mesenchymal Stem Cells Sales by Application (2012-2017)
    7.4 United States Mesenchymal Stem Cells Sales, Revenue and Market Share by Manufacturer
        7.4.1 United States Mesenchymal Stem Cells Sales and Market Share by Manufacturer
        7.4.2 United States Mesenchymal Stem Cells Revenue and Market Share by Manufacturer
    7.5 United States Mesenchymal Stem Cells Export and Import (2012-2017)
8 Canada Mesenchymal Stem Cells Sales, Revenue, by Type, Application and Manufacturers
    8.1 Canada Mesenchymal Stem Cells Revenue, Sales and Growth Rate (2012-2017)
    8.2 Canada Mesenchymal Stem Cells Sales and Market Share by Type
    8.3 Canada Mesenchymal Stem Cells Sales by Application (2012-2017)
    8.4 Canada Mesenchymal Stem Cells Sales, Revenue and Market Share by Manufacturer
        8.4.1 Canada Mesenchymal Stem Cells Sales and Market Share by Manufacturer
        8.4.2 Canada Mesenchymal Stem Cells Revenue and Market Share by Manufacturer
    8.5 Canada Mesenchymal Stem Cells Export and Import (2012-2017)
9 Mexico Mesenchymal Stem Cells Sales, Revenue, by Type, Application and Manufacturers
    9.1 Mexico Mesenchymal Stem Cells Revenue, Sales and Growth Rate (2012-2017)
    9.2 Mexico Mesenchymal Stem Cells Sales and Market Share by Type
    9.3 Mexico Mesenchymal Stem Cells Sales by Application (2012-2017)
    9.4 Mexico Mesenchymal Stem Cells Sales, Revenue and Market Share by Manufacturer
        9.4.1 Mexico Mesenchymal Stem Cells Sales and Market Share by Manufacturer
        9.4.2 Mexico Mesenchymal Stem Cells Revenue and Market Share by Manufacturer
    9.5 Mexico Mesenchymal Stem Cells Export and Import (2012-2017)
10 Mesenchymal Stem Cells Market Forecast (2017-2022)
    10.1 North America Mesenchymal Stem Cells Sales, Revenue and Growth Rate (2017-2022)
    10.2 Mesenchymal Stem Cells Market Forecast by Countries (2017-2022)
        10.2.1 United States Mesenchymal Stem Cells Forecast (2017-2022)
        10.2.2 Canada Mesenchymal Stem Cells Forecast (2017-2022)
        10.2.3 Mexico Mesenchymal Stem Cells Forecast (2017-2022)
    10.3 Mesenchymal Stem Cells Market Forecast by Type (2017-2022)
    10.4 Mesenchymal Stem Cells Market Forecast by Application (2017-2022)
11 Mesenchymal Stem Cells Manufacturing Cost Analysis
    11.1 Mesenchymal Stem Cells Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Mesenchymal Stem Cells
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Mesenchymal Stem Cells Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Mesenchymal Stem Cells Major Manufacturers in 2016
    12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Analyst Introduction
    15.3 Data Source